Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-18

Clinical Trial Update: Minocycline Administration During Human Liver Transplantation [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating minocycline administration during human liver transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Liver Disease | Phase 4 | Status: WITHDRAWN